News Medical on MSN2d
SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission, clinical trial findsAdults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor ...
News Medical on MSN1d
Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesityFindings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing ...
The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists.
It’s been a tough start to the year for the NHS. This month, 24 NHS trusts in England declared a critical incident owing to overwhelming demand in emergency departments. Pressures were exacerbated by ...
The Brighterside of News on MSN3d
Researchers reveal benefits, risks linked to popular weight-loss drugsGlucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart ...
Examples of therapeutics include drug therapy ... DPP4 inhibitors and SGLT2 inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback